Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RING1 and YY1-binding protein (RYBP), also known as Death effector domain-associated factor (DEDAF), is a multifunctional protein that plays a critical role in both transcriptional regulation and the execution of apoptosis (UniProt Q8N488). As a member of the Polycomb group (PcG) proteins, RYBP is a core component of non-canonical Polycomb Repressive Complex 1 (PRC1), where it facilitates histone H2A ubiquitination and gene silencing (PubMed: 25483080). In the context of cell death, RYBP/DEDAF interacts with death effector domains (DEDs) of proteins like FADD and procaspase-8, significantly enhancing the assembly of the death-inducing signaling complex (DISC) and promoting apoptosis (PubMed: 11084014). Due to its frequent downregulation in various malignancies, including lung and liver cancers, it is primarily characterized as a tumor suppressor (PubMed: 25483080). While there are currently no FDA-approved drugs specifically targeting RYBP, its central role in epigenetic regulation and apoptotic pathways makes it a subject of interest for therapeutic strategies aimed at restoring its expression or activity in cancer cells (NCBI Gene ID: 23429).
Enhancement of death-inducing signaling complex (DISC) assembly and stabilization of non-canonical Polycomb Repressive Complex 1 (PRC1) for epigenetic gene silencing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RING1 and YY1-binding protein (RYBP) (RYBP).